Maybe you've noticed it on your blood work, or perhaps you've heard other guys in TRT forums talking about it
Miao Y, Chen Y, Xue F, Liu K, Zhu B, Gao J
Given that the formal FDA reclassification has been announced but not yet officially published, patients and physicians are in a period of transition
[1] The authors described a neurohumoral modulating and programming activity deliberately vague language, not a claim of sedation
Key Benefits of PDA: Tendon healing Decrease pain & inflammation Increase collagen synthesis Quicker recovery times post-injury Wound & bone healing Intestinal issues Repair of the brain-gut axis Positive effects on the central nervous system affecting the peripheral nervous system & pain Reduce symptoms of depression Protects the heart Beneficial effects on stroke, schizophrenia, & spinal cord injuries Helps reverse opioid tolerance Increase neurotransmission with dopamine, serotonin, Gaba, &opioid receptors to reduce perception of pain The peptide experts at All U Health have treated many patients with this peptide & have had great success, such as we did when our patients used BPC-157
This allowed for inclusion of a broad range of GLP-1 patients and strong real-world outcomes assessment with well-powered subgroup analyses by key patient features and indications